An overview of chemotherapy trials in localized and recurrent nonmetastatic prostate cancer Article Conference Paper uri icon

Overview

MeSH Major

  • Fluorodeoxyglucose F18
  • HSP90 Heat-Shock Proteins
  • Positron-Emission Tomography
  • Receptor, ErbB-2

abstract

  • Chemotherapy is being investigated actively in randomized trials of earlier states of prostate cancer. Enrollment onto clinical trials should be the highest priority for investigators and clinicians.

publication date

  • November 2004

Research

keywords

  • Conference Paper

Identity

Digital Object Identifier (DOI)

  • 10.1097/01.ju.0000141674.92253.fe

PubMed ID

  • 15535440

Additional Document Info

start page

  • S34

end page

  • 7; discussion S37

volume

  • 172

number

  • 5 II